Dawn R Cochrane

15PUBLICATIONS
61CO-AUTHORS
Chemical engineering designCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologySolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 22, 2026
Ciliated Cells Drive Critical STING-Mediated Tumor Suppression in the Fallopian Tube Epithelium.

|Apr 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma.

Spencer D Martin, Shelby Thornton, Christine Chow

|Dec 17, 2024
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas.

Ardalan Akbari, Jennifer Pors, Amy Lum

|Aug 03, 2024
The unique metabolome of clear cell ovarian carcinoma.

Jennifer X Ji, Lien N Hoang, Dawn R Cochrane

|Jul 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinoma.

Rodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri

|Mar 27, 2024
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers.

Amy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane

Pageof 3

Frequent Collaborators

10 joint publications

David Huntsman

4 joint publications

Jutta Huvila

4 joint publications

C Blake Gilks

3 joint publications

Gian Luca Negri